Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System | NCT03960905 | Wei Zhao | user2@example.com | None | 2019-01-01 | 2020-12-31 | 2021-12-31 | - | - | 2025-07-14 |
| The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China | NCT04228393 | Wei Zhao | user2@example.com | None | 2020-02-01 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Therapeutic Drug Monitoring of Anxiolytics in Children | NCT03960671 | Wei Zhao | user2@example.com | None | 2018-08-01 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Antiepileptic Drugs in Elderly Patients | NCT05459597 | Wei Zhao | user2@example.com | None | 2021-01-01 | 2028-06-30 | 2029-06-30 | - | - | 2025-07-14 |
| Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease | NCT03844360 | Wei Zhao | user2@example.com | None | 2016-01-31 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |